Peter Q Eichacker Selected Research

Peter Q Eichacker Research Topics

Disease

47	Sepsis (Septicemia) 12/2021 - 09/2002
19	Anthrax 01/2021 - 04/2004
17	Infections 01/2023 - 07/2003
17	Edema (Dropsy) 01/2021 - 11/2005
17	Shock 01/2021 - 04/2004
12	Septic Shock (Toxic Shock Syndrome) 01/2021 - 06/2004
6	Inflammation (Inflammations) 01/2023 - 03/2006
5	Pneumonia (Pneumonitis) 01/2023 - 11/2003
4	Critical Illness (Critically Ill) 08/2023 - 09/2002
4	Staphylococcal Pneumonia 12/2021 - 07/2003
4	Hypotension (Low Blood Pressure) 11/2017 - 08/2006
4	Lung Injury 05/2011 - 11/2003
3	Body Weight (Weight, Body) 01/2018 - 03/2003
2	Hypoxia (Hypoxemia) 01/2023 - 01/2021
2	COVID-19 01/2023 - 01/2022
2	Neoplasms (Cancer) 01/2023 - 01/2022
2	Bacterial Infections (Bacterial Infection) 02/2020 - 11/2003
2	Disseminated Intravascular Coagulation 10/2013 - 09/2013
2	Thrombosis (Thrombus) 05/2011 - 06/2004
2	Hemorrhage 01/2009 - 01/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2024
1	Hepatitis 01/2023
1	Virus Diseases (Viral Diseases) 11/2021
1	Obesity 01/2020
1	Human Influenza (Influenza) 01/2020
1	Soft Tissue Infections 01/2017
1	Acute Lung Injury 10/2014
1	Necrosis 10/2013

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 01/2021 - 02/2005
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 02/2010
8	Protein CIBA 01/2009 - 09/2002
7	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2020 - 11/2002
6	edema factorIBA 01/2021 - 02/2007
6	LipopolysaccharidesIBA 01/2020 - 03/2006
6	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2014 - 06/2004
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 03/2003
5	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2021 - 02/2007
5	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2020 - 07/2004
4	Immune Checkpoint InhibitorsIBA 01/2023 - 02/2020
4	anthrax toxin (anthrax lethal factor)IBA 01/2021 - 06/2007
4	Lactic Acid (Lactate)FDA LinkGeneric 02/2020 - 01/2012
4	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2017 - 12/2004
4	Monoclonal AntibodiesIBA 06/2011 - 02/2005
4	CytokinesIBA 05/2011 - 04/2004
3	adefovirIBA 01/2021 - 03/2011
3	Peptidoglycan (Murein)IBA 11/2020 - 09/2013
3	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 11/2017 - 07/2013
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 04/2004
3	GlucocorticoidsIBA 01/2012 - 07/2004
3	E5564IBA 04/2011 - 03/2006
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2005 - 09/2002
2	AntibodiesIBA 01/2023 - 10/2013
2	Anthrax Immune Globulin IntravenousIBA 01/2021 - 01/2017
2	raxibacumabIBA 01/2021 - 12/2015
2	Immunoglobulins (Immunoglobulin)IBA 10/2017 - 09/2014
2	Saline SolutionIBA 10/2017 - 06/2007
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2014 - 01/2012
2	AldosteroneIBA 12/2014 - 01/2012
2	Heroin (Diamorphine)IBA 07/2012 - 12/2011
2	Coloring Agents (Dyes)IBA 07/2012 - 12/2011
2	Heparin (Liquaemin)FDA LinkGeneric 05/2011 - 04/2009
2	eritoranIBA 04/2011 - 01/2010
2	ethyl pyruvateIBA 08/2009 - 04/2008
2	parthenolideIBA 08/2009 - 03/2006
2	NF-kappa B (NF-kB)IBA 08/2009 - 04/2008
2	CoagulantsIBA 01/2009 - 06/2004
2	CreatinineIBA 01/2009 - 03/2003
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2007 - 02/2007
2	EndotoxinsIBA 03/2006 - 03/2003
2	AnticoagulantsIBA 04/2005 - 06/2004
2	Bacterial ToxinsIBA 04/2004 - 03/2003
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2023
1	LigandsIBA 12/2021
1	Programmed Cell Death 1 ReceptorIBA 12/2021
1	Chloroquine (Aralen)FDA LinkGeneric 11/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2021
1	Antiviral Agents (Antivirals)IBA 11/2021
1	AntitoxinsIBA 01/2021
1	obiltoxaximabIBA 01/2021
1	cyclopropapyrroloindoleIBA 02/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	ExotoxinsIBA 12/2017
1	SodiumIBA 01/2017
1	Cyclic AMP (AMP, Cyclic)IBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 12/2014
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2014
1	boldenone undecylenate (Equipoise)IBA 10/2014
1	Metalloproteases (Metalloproteinases)IBA 10/2013
1	Dacarbazine (DIC)FDA LinkGeneric 09/2013
1	Interleukin-6 (Interleukin 6)IBA 12/2012
1	Oxacillin (Prostaphlin)FDA LinkGeneric 12/2012

Therapy/Procedure

32	Therapeutics 01/2023 - 11/2002
2	Critical Care (Surgical Intensive Care) 08/2023 - 06/2007
2	Early Goal-Directed Therapy 08/2015 - 02/2010
1	Erythrocyte Transfusion 05/2024
1	Ligation 01/2020
1	Punctures 01/2020
1	Controlled Hypotension 11/2017
1	Patient Care Bundles 10/2013